Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
0(0%)
Results Posted
17%(1 trials)

Phase Distribution

Ph phase_1
2
33%
Ph phase_3
1
17%
Ph early_phase_1
1
17%
Ph phase_2
2
33%

Phase Distribution

3

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution6 total trials
Early Phase 1First-in-human
1(16.7%)
Phase 1Safety & dosage
2(33.3%)
Phase 2Efficacy & side effects
2(33.3%)
Phase 3Large-scale testing
1(16.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Completed(6)

Detailed Status

Completed6

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Early Phase 11 (16.7%)
Phase 12 (33.3%)
Phase 22 (33.3%)
Phase 31 (16.7%)

Trials by Status

completed6100%

Recent Activity

0 active trials
Showing 5 of 6
completedphase_1

Interventional Study of Mucosal and Antimicrobial Responses to Repeated Vaginal Applications of Tenofovir Gel in HIV Uninfected Women

NCT00594373
completedphase_2

Adherence and Acceptability to and Blood Levels of Tenofovir Gel and Tablets in HIV Uninfected Women

NCT00592124
completedphase_2

Safety and Effectiveness Study of a Candidate Vaginal Microbicide for Prevention of HIV

NCT00441298
completedearly_phase_1

Comparison of Tenofovir Vaginal Gel and Film Formulations

NCT02280109
completedphase_3

Safety and Effectiveness of Tenofovir Gel in the Prevention of Human Immunodeficiency Virus (HIV-1) Infection in Women and the Effects of Tenofovir Gel on the Incidence of Herpes Simplex Virus (HSV-2) Infection

NCT01386294
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT00594373Phase 1

Interventional Study of Mucosal and Antimicrobial Responses to Repeated Vaginal Applications of Tenofovir Gel in HIV Uninfected Women

Completed
NCT00592124Phase 2

Adherence and Acceptability to and Blood Levels of Tenofovir Gel and Tablets in HIV Uninfected Women

Completed
NCT00441298Phase 2

Safety and Effectiveness Study of a Candidate Vaginal Microbicide for Prevention of HIV

Completed
NCT02280109Early Phase 1

Comparison of Tenofovir Vaginal Gel and Film Formulations

Completed
NCT01386294Phase 3

Safety and Effectiveness of Tenofovir Gel in the Prevention of Human Immunodeficiency Virus (HIV-1) Infection in Women and the Effects of Tenofovir Gel on the Incidence of Herpes Simplex Virus (HSV-2) Infection

Completed
NCT00561496Phase 1

Pharmacokinetic Study of the Vaginal Microbicide Agent 1% Tenofovir Gel

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6